Instrument Inactif

Communiqués Atlas Cloud Enterprises Inc Canadian Securities Exchange

Actions

AKE

CA0492371004

Cours en clôture Canadian Securities Exchange Autres places de cotation
-	-

26/04/24	Isracann Biosciences Inc. annonce la démission de ses administrateurs	CI
23/01/24	Isracann Biosciences Inc. annonce des changements au sein de sa direction	CI

Communiqués

04/09/24	CSE Bulletin: Delist - Isracann Biosciences Inc. (IPOT)	NE
06/04/23	CSE Bulletin: Suspensions (IPOT, TCAN)	NE
06/04/23	IIROC Trading Halt - IPOT	AQ
13/10/22	Isracann Biosciences Provides Bi-Weekly Default Status Report	GL
30/09/22	Isracann Biosciences Announces Delay in Filing Annual Financial Statements	GL
28/09/22	Isracann Bioscience Facilitated Genetics Arrive in Israel	AQ
28/09/22	Isracann Bioscience Facilitated Genetics Arrive in Israel	GL
14/09/22	Isracann Bioscience Facilitates Cannabis Genetics Shipment to Israel	GL
02/09/22	Isracann Biosciences Inc. - Praesidio signs distribution agreement with Pure Integrative Pharmacy	AQ
01/09/22	Praesidio signs distribution agreement with Pure Integrative Pharmacy	AQ
01/09/22	Praesidio signs distribution agreement with Pure Integrative Pharmacy	GL
23/08/22	Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board	AQ
23/08/22	Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board	GL
03/08/22	Isracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private Placement	AQ
03/08/22	Isracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private Placement	GL
19/05/22	Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada	GL
15/04/22	Isracann Biosciences Renews Leadership to Meet Changing Demands	AQ
13/04/22	Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers	GL
28/03/22	Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer	GL
24/02/22	UPDATE - Isracann Signs LOI to Acquire Natural Health Medicine Developer	GL
23/02/22	Isracann Signs LOI to Acquire Natural Health Medicine Developer	AQ
20/10/21	Isracann Biosciences : Appoints Operational Expert Phil Floucault as CEO and Grants Options	AQ
31/08/21	Isracann Biosciences : Appoints Experienced Farm Manager and Updates Israeli Cannabis Operations	AQ
21/04/21	Isracann Biosciences : Receives Foreign Owners License and Updates Israeli Cannabis Operations	AQ
18/03/21	Isracann Biosciences : Applauds Expanded Cannabis Accessibility	AQ